This company listing is no longer active
This company may still be operating, however this listing is no longer active. Find out why through their latest events.
Epizyme Management
Management criteria checks 2/4
Key information
Grant Bogle
Chief executive officer
US$3.0m
Total compensation
| CEO salary percentage | 9.9% |
| CEO tenure | less than a year |
| CEO ownership | n/a |
| Management average tenure | 2.3yrs |
| Board average tenure | 10.2yrs |
Recent management updates
Recent updates
Epizyme GAAP EPS of -$0.21, revenue of $27.5M
Aug 09Epizyme Acquisition By Ipsen: CVR Value
Jul 05Some Epizyme, Inc. (NASDAQ:EPZM) Analysts Just Made A Major Cut To Next Year's Estimates
May 16
Epizyme: Taking Advantage Of Recent Sell-Off
Nov 25Health Check: How Prudently Does Epizyme (NASDAQ:EPZM) Use Debt?
Sep 14Industry Analysts Just Made A Sizeable Upgrade To Their Epizyme, Inc. (NASDAQ:EPZM) Revenue Forecasts
Aug 10Epizyme: Potential Comeback With Tazemetostat After Initial Sales Challenge
Jun 22Is Epizyme (NASDAQ:EPZM) Using Too Much Debt?
Jun 08Epizyme gains as peer Constellation attracts sizable premium from MorphoSys
Jun 02Epizyme, Inc. 2021 Q1 - Results - Earnings Call Presentation
May 07Epizyme, Inc. (NASDAQ:EPZM) Analysts Just Trimmed Their Revenue Forecasts By 41%
Feb 25Is Epizyme (NASDAQ:EPZM) Using Too Much Debt?
Jan 16
Epizyme says Boehringer terminates collaboration agreement
Dec 24Would Shareholders Who Purchased Epizyme's (NASDAQ:EPZM) Stock Year Be Happy With The Share price Today?
Dec 12Epizyme Q3 2020 Earnings Preview
Nov 05CEO Compensation Analysis
| Date | Total Compensation | Salary | Company Earnings |
|---|---|---|---|
| Jun 30 2022 | n/a | n/a | -US$208m |
| Mar 31 2022 | n/a | n/a | -US$236m |
| Dec 31 2021 | US$3m | US$299k | -US$251m |
| Sep 30 2021 | n/a | n/a | -US$267m |
| Jun 30 2021 | n/a | n/a | -US$257m |
| Mar 31 2021 | n/a | n/a | -US$251m |
| Dec 31 2020 | US$196k | n/a | -US$232m |
| Sep 30 2020 | n/a | n/a | -US$222m |
| Jun 30 2020 | n/a | n/a | -US$202m |
| Mar 31 2020 | n/a | n/a | -US$192m |
| Dec 31 2019 | US$309k | n/a | -US$173m |
Compensation vs Market: Grant's total compensation ($USD3.01M) is above average for companies of similar size in the US market ($USD1.66M).
Compensation vs Earnings: Grant's compensation has increased whilst the company is unprofitable.
CEO
Grant Bogle (64 yo)
less than a year
Tenure
US$3,011,807
Compensation
Mr. Grant C. Bogle has been Chief Executive Officer, President and Director at Epizyme, Inc. since August 9, 2021 and serves as Principal Financial Officer since November 1, 2021 and served as its Independ...
Leadership Team
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| President | less than a year | US$3.01m | no data | |
| Chief Scientific Officer | 2.3yrs | US$2.86m | 0.0080% $ 19.9k | |
| Co-Founder & Chairman of the Scientific Advisory Board | no data | no data | no data | |
| Scientific Co-Founder & Member of The Scientific Advisory Board | no data | no data | no data | |
| Chief Operating Officer | less than a year | no data | no data | |
| Senior VP | 4.1yrs | no data | 0.0058% $ 14.3k | |
| Vice President of Investor Relations | no data | no data | no data | |
| Senior VP | no data | no data | no data | |
| Chief Business Officer | 3.6yrs | no data | no data | |
| Chief Regulatory Officer | 2.8yrs | no data | no data | |
| Senior VP & Head of Commercial | less than a year | no data | no data | |
| Laboratory Manager of Research & Development | no data | no data | no data |
2.3yrs
Average Tenure
56.5yo
Average Age
Experienced Management: EPZM's management team is considered experienced (2.3 years average tenure).
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| President | 2.9yrs | US$3.01m | no data | |
| Co-Founder & Chairman of the Scientific Advisory Board | no data | no data | no data | |
| Scientific Co-Founder & Member of The Scientific Advisory Board | no data | no data | no data | |
| Member of the Scientific Advisory Board | no data | no data | no data | |
| Independent Chairman | 12.7yrs | US$370.00k | 0.19% $ 474.0k | |
| Independent Director | 12.9yrs | US$350.00k | 0.0030% $ 7.4k | |
| Member of the Scientific Advisory Board | no data | no data | no data | |
| Independent Director | 7.7yrs | US$330.94k | 0% $ 0 | |
| Member of the Scientific Advisory Board | no data | no data | no data | |
| Member of the Scientific Advisory Board | no data | no data | no data | |
| Member of the Scientific Advisory Board | no data | no data | no data | |
| Member of the Scientific Advisory Board | no data | no data | no data |
10.2yrs
Average Tenure
68yo
Average Age
Experienced Board: EPZM's board of directors are seasoned and experienced ( 10.2 years average tenure).